Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Drug-Drug Interactions With Oral Antineoplastic Agents.
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer.
Radiation dose =54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.
Reducing alcohol and/or cocaine-induced reward and toxicity via an epidermal stem cell-based gene delivery platform.
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nat Med. 2022 08; 28(8):1581-1589.
View in:
PubMed
subject areas
Adolescent
Adult
Biomarkers, Tumor
Child
Child, Preschool
Genomics
High-Throughput Nucleotide Sequencing
Humans
Infant
Infant, Newborn
Molecular Targeted Therapy
Neoplasms
Prospective Studies
Young Adult
authors with profiles
Samuel L. Volchenboum
Mark Applebaum